Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

A2 Milk’s (ASX:A2M) share price drops on FDA notification

Stock Markets Aug 10, 2022 13:00
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. A2 Milk’s (ASX:A2M) share price drops on FDA notification
 
A2M
+0.56%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
BUB
0.00%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Highlights:

  • Dual-listed a2 Milk Company has informed that its application to import baby milk formula to the US has been deferred by the US FDA.
  • Earlier this month, a2MC had stated that its application is under active review, but it is not certain whether it would receive approval or not.
  • On the ASX, the share price of a2MC dropped by more than 9% (as of 11:12 AM AEST).

Dairy nutritional company, The A2 Milk Company Ltd (ASX:A2M), on Wednesday, (10 August 2022) shared that it has received a notification from the US Food and Drug Administration (FDA). FDA has informed the company that it is deferring its request for enforcement discretion to import the company’s baby milk formula into the US.

International Dairy Foods Association (IDFA) has advised the organisation that the FDA is deferring further consideration of all the pending applications at this time. Reportedly, FDA has not provided any reason for deferring the company’s request.

a2 Milk Company is a dual-listed company with its listing on ASX and NZX. The company is focused on products that contain the A2 beta-casein protein type. The company has products in North America, Greater China, Australia, New Zealand and a selection of emerging markets.

How are a2 Milk Company shares responding to the news?

The share price of a2 Milk Company was spotted 9.197% lower at AU$4.640 per share at 11:12 AM AEST.

With this, the share price has been dragged down by 15.77% on year-to-date basis. And in last one year, the share price has fallen by 20.47%. In last six months, it has gone down by 14.23%. The monthly gain stands at 4.91%.

More on the FDA approval to import a2MC’s baby milk formula products

Earlier this month, a2MC informed the market that its application to import infant milk formula to the US is under active review. In the announcement (dated 2 August 2022), the company said that there is no certainty that it would get approval.

Australian and New Zealand dairy companies are on their feet to get approval to restock the shelves of the US as the country relaxed its import policy under a temporary program. The US relaxed its import standards as it is going through one of the largest infant formula shortages.

Australian milk company, Bubs Australia Ltd (ASX:BUB) has sent several batches of infant formula to the US. Other companies like Nestle SA (SIX:NESN), UK-based Kendamil and Danone SA (EPA:DANO) are putting their products on shelves of US supermarkets.

Many companies are still waiting to get approvals, including a2MC.

Read more on Kalkine Media

A2 Milk’s (ASX:A2M) share price drops on FDA notification
 

Related Articles

Adobe Earnings, Revenue miss in Q4
Adobe Earnings, Revenue miss in Q4 By Investing.com - Oct 01, 2022 4

Investing.com - Adobe (NASDAQ:ADBE) reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. Adobe announced...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email